BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 8159357)

  • 21. [Treatment of acute leukemia by differentiation: effects of all trans retinoic acid in acute promyelocytic leukemia].
    Degos L
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):193-5. PubMed ID: 8337123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Successful treatment of subdural hematoma with operation in a patient with acute promyelocytic leukemia].
    Okubo C; Kanamori H; Sasaki S; Taguchi J; Otsuka M; Harano H; Ogawa K; Matsuzaki M; Mohri H; Okubo T
    Rinsho Ketsueki; 1997 Jun; 38(6):539-43. PubMed ID: 9248331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [All-trans retinoic acid-induced myelomonocytoid differentiation in acute promyelocytic leukemia].
    Mori H; Fujiwara H; Takahashi N; Tada J; Higuchi T; Harada H; Niikura H; Omine M; Fujita K
    Rinsho Ketsueki; 1997 May; 38(5):440-4. PubMed ID: 9194390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Induction of hematologic remission in a patient with acute promyelocytic leukemia through the therapeutic use of trans-retinoic acid].
    Skotnicki AB; Stoch A; Sacha T; Nowak WS
    Acta Haematol Pol; 1994; 25(1):69-74. PubMed ID: 8209619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. All-trans retinoic acid (ATRA) administration during pregnancy in relapsed acute promyelocytic leukemia.
    Simone MD; Stasi R; Venditti A; Del Poeta G; Aronica G; Bruno A; Masi M; Tribalto M; Papa G; Amadori S
    Leukemia; 1995 Aug; 9(8):1412-3. PubMed ID: 7643633
    [No Abstract]   [Full Text] [Related]  

  • 27. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
    Dombret H; Scrobohaci ML; Ghorra P; Zini JM; Daniel MT; Castaigne S; Degos L
    Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fatal thromboembolism in acute promyelocytic leukemia during all-trans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage.
    Hashimoto S; Koike T; Tatewaki W; Seki Y; Sato N; Azegami T; Tsukada N; Takahashi H; Kimura H; Ueno M
    Leukemia; 1994 Jul; 8(7):1113-5. PubMed ID: 8035603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant human soluble thrombomodulin safely and effectively rescues acute promyelocytic leukemia patients from disseminated intravascular coagulation.
    Ikezoe T; Takeuchi A; Isaka M; Arakawa Y; Iwabu N; Kin T; Anabuki K; Sakai M; Taniguchi A; Togitani K; Yokoyama A
    Leuk Res; 2012 Nov; 36(11):1398-402. PubMed ID: 22917769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute myelogenous leukemia in pregnancy.
    D'Emilio A; Dragone P; De Negri G; Montaldi A; Stella M; Battista R
    Haematologica; 1989; 74(6):601-4. PubMed ID: 2628244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia.
    Huang ME; Ye YC; Chen SR; Chai JR; Lu JX; Zhao L; Gu LJ; Wang ZY
    Haematol Blood Transfus; 1989; 32():88-96. PubMed ID: 2696695
    [No Abstract]   [Full Text] [Related]  

  • 32. Acute promyelocytic leukemia and pregnancy. A case report.
    Hoffman MA; Wiernik PH; Kleiner GJ
    Cancer; 1995 Dec; 76(11):2237-41. PubMed ID: 8635026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia.
    Quezada G; Kopp L; Estey E; Wells RJ
    Pediatr Blood Cancer; 2008 Jul; 51(1):133-5. PubMed ID: 18293388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acute promyelocytic leukemia following ulcerative colitis].
    Suzuki Y; Nakase K; Nagaya S; Tamaki S; Tanigawa M; Ikeda T; Tsuji K; Miyanishi E
    Rinsho Ketsueki; 1995 Jul; 36(7):707-9. PubMed ID: 7563602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule.
    Zubizarreta PA; Rose AB; Felice MS; Alfaro E; Delfino S; Cygler AM; Sackmann-Muriel F
    Pediatr Hematol Oncol; 2000 Mar; 17(2):155-62. PubMed ID: 10734658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute promyelocytic leukemia (AML-M3)--Part 1: Pathophysiology, clinical diagnosis, and differentiation therapy.
    Randolph TR
    Clin Lab Sci; 2000; 13(2):98-105. PubMed ID: 11066455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute promyelocytic leukemia (AML-M3)--Part 2: Molecular defect, DNA diagnosis, and proposed models of leukemogenesis and differentiation therapy.
    Randolph TR
    Clin Lab Sci; 2000; 13(2):106-16. PubMed ID: 11066449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acute promyelocytic leukemia relapse as leukemia cutis shortly after complete remission with all-trans retinoic acid].
    Itoh K; Gotoh W; Yagasaki F; Itoh Y; Kawai N; Matsuda A; Tominaga K; Kusumoto S; Ino H; Murohashi I; Jinnai I; Takeuchi H; Bessho M; Hirashima K
    Rinsho Ketsueki; 1998 Mar; 39(3):221-6. PubMed ID: 9577647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful use of all-trans retinoic acid in acute promyelocytic leukaemia presenting during the second trimester of pregnancy.
    Harrison P; Chipping P; Fothergill GA
    Br J Haematol; 1994 Mar; 86(3):681-2. PubMed ID: 8043456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of acute promyelocytic leukemia with all-trans retinoic acid during the third trimester of pregnancy.
    Watanabe R; Okamoto S; Moriki T; Kizaki M; Kawai Y; Ikeda Y
    Am J Hematol; 1995 Mar; 48(3):210-1. PubMed ID: 7864036
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.